Biofrontera, Inc. (BFRI)
0.7891
+0.01
(+1.04%)
USD |
NASDAQ |
Oct 23, 16:00
0.7801
-0.01
(-1.14%)
After-Hours: 20:00
Biofrontera Profit Margin (Quarterly) : -5.03% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.03% |
| March 31, 2026 | -47.12% |
| December 31, 2025 | 32.98% |
| September 30, 2025 | -95.15% |
| June 30, 2025 | -58.96% |
| March 31, 2025 | -48.94% |
| December 31, 2024 | -11.12% |
| September 30, 2024 | -62.90% |
| June 30, 2024 | -3.28% |
| March 31, 2024 | -131.9% |
| December 31, 2023 | 33.28% |
| September 30, 2023 | -71.29% |
| June 30, 2023 | -168.2% |
| Date | Value |
|---|---|
| March 31, 2023 | -85.63% |
| December 31, 2022 | -27.45% |
| September 30, 2022 | -59.37% |
| June 30, 2022 | -19.07% |
| March 31, 2022 | 57.03% |
| December 31, 2021 | -158.2% |
| September 30, 2021 | -369.5% |
| June 30, 2021 | -62.53% |
| March 31, 2021 | -74.49% |
| September 30, 2020 | -91.79% |
| June 30, 2020 | -154.5% |
| March 31, 2020 | -88.77% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 0.83% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -208.6% |
| Return on Assets | -28.17% |
| Return on Invested Capital | -68.36% |
| Gross Profit Margin (Quarterly) | 91.59% |
| Operating Margin (Quarterly) | 7.30% |
| Return on Net Operating Assets | -52.83% |